ResultsEconomic Times
Gland Pharma shares jump 4% as Q2 profit jumps 58%
Positive+41Company event
GreyOak summary
Gland Pharma shares rose 3.89% after reporting a 23% year-on-year revenue increase to Rs 1,834 crore and a 58% net profit surge to Rs 290.8 crore in the September 2026 quarter. The company's CDMO business grew 31%, while Critical Injectables rose 18%. Gland Pharma also launched four new molecules in the US and filed 11 ANDAs during the period.
What it affects
- Gland PharmaGLANDPositive +41
Shares jumped 4% on strong Q2 resultsRolling sentiment Positive +64
Source
Read the original at Economic TimesMore Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares rally 8% to hit 4-year-high post strong Q2Moneycontrol · Results ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divis, Gland, Sai Life Sciences shares hit 52-week highsBusiness Today · Stock view ·